Significant Ownership of Westlake BioPartners Fund I, L.P.

Location
Westlake Village, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Westlake BioPartners Fund I, L.P..

Notify me when Westlake BioPartners Fund I, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Westlake BioPartners Fund I, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
KYTX Kyverna Therapeutics, Inc. Common Stock, par value $0.00001 per share 7.8% $43,778,216 4,657,257 Dr. Beth C. Seidenberg ("Seidenberg") 31 Dec 2025

Schedules 13D/G Reported by Westlake BioPartners Fund I, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.